In vitro Susceptibility of Prototheca Species to Antifungal Agents
Abstract
Prototheca sp. can assume high economic significance in the dairy industry and pose a potential risk for the public health. Studies on the susceptibility of Prototheca spp. to antimicrobials have demonstrated its high level of resistance. We investigated the in vitro susceptibility of ten Prototheca zopfii isolates retrieved from mastitic milk and one P. wickerhamii referent strain, from American Type Collection using MIC Test Strip. P. zopfii isolats showed susceptibility to MIC between 1,5-4 μg/mL for ketoconazole, and between 1,5-3 μg/mL for amphotericin B. In contrast P. wickerhamii strain prouved to be efficient to a MIC of 2 μg/mL in case of ketoconazole and 0,75 μg/mL for amphotericin B. Both species tested showed to be resistant to itraconazole.This study demonstrates different in vitro susceptibility patterns of P. wickerhamii and P. zopfii, reinforcing the necessity for more investigation into drugs that can be used with clinical efficacy.
Authors who publish with this journal agree to the following terms:a) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
